The Role of Host Cell Glycans on Virus Infectivity: The SARS‐CoV‐2 Case
Source abstract
Abstract
Abstract Glycans are ubiquitously expressed sugars, coating the cell and protein surfaces. They are found on many proteins as either short and branched chains or long chains sticking out from special membrane proteins, known as proteoglycans. This sugar cushion, the glycocalyx, modulates specific interactions and protects the cell. Here it is shown that both the expression of proteoglycans and the glycans expressed on the surface of both the host and virus proteins have a critical role in modulating viral attachment to the cell. A mathematical model using SARS‐Cov‐2 as an archetypical virus to study the glycan role during infection is proposed. It is shown that this occurs via a tug‐of‐war of forces. On one side, the multivalent molecular recognition that viral proteins have toward specific host glycans and receptors. On the other side, the glycan steric repulsion that a virus must overcome to approach such specific receptors. By balancing both interactions, viral tropism can be predicted. In other words, the authors can map out the cells susceptible to virus infection in terms of receptors and proteoglycans compositions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: SARS-CoV-2 and COVID-19 Research · Diabetes and associated disorders · COVID-19 Clinical Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute for the Physics of Living Systems University College London London Central London UK
Institute of Structural and Molecular Biology University College London London Central London UK
Department of Chemistry University College London 20 Gordon St London Central London WC1H 0AJ UK
Institute for Bioengineering of Catalunya (IBEC) The Barcelona Institute of Science and Technology Barcelona Barcelona 08028 Spain
Catalan Institution for Research and Advances Studies (ICREA) Barcelona Spain
Funding
European Research Council
References (55)
Show source-provided references
1. 10.1093/femspd/ftaa00610.1093/femspd/ftaa006 ↗
2. 10.1016/S0092-8674(00)80882-X10.1016/S0092-8674(00)80882-X ↗
3. 10.1126/science.105861310.1126/science.1058613 ↗
4. 10.1038/nrmicro81710.1038/nrmicro817 ↗
5. 10.1073/pnas.110535110810.1073/pnas.1105351108 ↗
6. 10.3390/v1107059610.3390/v11070596 ↗
7. 10.1128/JVI.01933-1710.1128/JVI.01933-17 ↗
8. 10.1038/nature0214510.1038/nature02145 ↗
9. 10.1016/j.cell.2020.09.03310.1016/j.cell.2020.09.033 ↗
10. 10.1021/acscentsci.1c0001010.1021/acscentsci.1c00010 ↗
11. 10.1016/j.antiviral.2020.10487310.1016/j.antiviral.2020.104873 ↗
12. 10.1038/nature1200510.1038/nature12005 ↗
13. 10.1016/j.sbi.2022.10243910.1016/j.sbi.2022.102439 ↗
14. 10.1016/j.cell.2020.02.05210.1016/j.cell.2020.02.052 ↗
15. 10.1038/s42255-020-00324-010.1038/s42255-020-00324-0 ↗
16. 10.1038/s41467-020-18603-510.1038/s41467-020-18603-5 ↗
17. 10.1126/sciadv.aat091910.1126/sciadv.aat0919 ↗
18. 10.1007/978-3-642-23056-1_810.1007/978-3-642-23056-1_8 ↗
19. 10.1016/j.bbagen.2015.10.01610.1016/j.bbagen.2015.10.016 ↗
20. 10.1016/j.tim.2007.03.00310.1016/j.tim.2007.03.003 ↗
21. 10.1093/glycob/cwaa04210.1093/glycob/cwaa042 ↗
22. 10.1126/science.abb998310.1126/science.abb9983 ↗
23. 10.1038/s41598-020-71748-710.1038/s41598-020-71748-7 ↗
24. 10.1021/acscentsci.0c0105610.1021/acscentsci.0c01056 ↗
25. Sztain T. · bioRxiv · 2021
26. 10.1016/j.cell.2020.02.05810.1016/j.cell.2020.02.058 ↗
27. 10.1038/s41423-020-0458-z10.1038/s41423-020-0458-z ↗
28. 10.1126/science.abb250710.1126/science.abb2507 ↗
29. 10.1038/s41586-020-2180-510.1038/s41586-020-2180-5 ↗
30. 10.1016/j.jmb.2020.16676210.1016/j.jmb.2020.166762 ↗
31. 10.1038/s41598-020-62074-z10.1038/s41598-020-62074-z ↗
32. 10.1016/S2213-2600(20)30193-410.1016/S2213-2600(20)30193-4 ↗
33. 10.1038/s41586-020-2196-x10.1038/s41586-020-2196-x ↗
34. 10.1136/bmj.m144310.1136/bmj.m1443 ↗
35. 10.1136/bmj.m386210.1136/bmj.m3862 ↗
36. 10.1126/sciadv.abc580110.1126/sciadv.abc5801 ↗
37. 10.1038/s41593-020-0587-910.1038/s41593-020-0587-9 ↗
38. 10.1164/rccm.201911-2199OC10.1164/rccm.201911-2199OC ↗
39. 10.1074/jbc.M111.32580310.1074/jbc.M111.325803 ↗
40. 10.7554/eLife.6131210.7554/eLife.61312 ↗
41. 10.1016/j.chom.2021.02.00310.1016/j.chom.2021.02.003 ↗
42. d)P.Horby C.Huntley N.Davies J.Edmunds N.Ferguson G.Medley C.Semple SAGE meeting report 2021;
43. e)B. J.Resende PC J. FelipeBezerra R. H. T. deVasconcelos I.Arantes L.Appolinario A. C.Mendonça A. C.Paixao A. C.Duarte Rodrigues T.Silva A. S.Rocha A.Pauvolid‐Corrêa F. CoutoMotta D. L. F.Teixeira T. F.deOliveira Carneiro F. P.Freire Neto I.Diniz Herbster A.Brandao Leite I. N.Riediger M.do Carmo Debur F. GomesNaveca W.Almeida M.Livorati G.Bello M. M.Siqueira Spike E484K mutation in the first SARS‐CoV‐2 reinfection case confirmed in Brazil https://virological.org/(accessed: March 2022).
44. 10.1038/s41591-021-01270-410.1038/s41591-021-01270-4 ↗
45. 10.1126/science.abd522310.1126/science.abd5223 ↗
46. 10.1038/s41586-020-2665-210.1038/s41586-020-2665-2 ↗
47. 10.1126/science.abb276210.1126/science.abb2762 ↗
48. W. Group (2005‐2020) GLYCAM Web. Complex Carbohydrate Research Center University of Georgia Athens GA.http://glycam.org(accessed: December 2020).
49. 10.1063/1.44586910.1063/1.445869 ↗
50. 10.1038/nmeth.406710.1038/nmeth.4067 ↗
51. 10.1016/j.softx.2015.06.00110.1016/j.softx.2015.06.001 ↗
52. 10.1063/1.240842010.1063/1.2408420 ↗
53. 10.1063/1.32869310.1063/1.328693 ↗
54. 10.1016/j.cpc.2013.09.01810.1016/j.cpc.2013.09.018 ↗
55. 10.1038/s41592-019-0475-y10.1038/s41592-019-0475-y ↗